Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
NVS
Stock Latest News
Market News
The Week That Was, The Week Ahead: Macro and Markets, July 19
21h ago
T
BX
Premium
Pre-Earnings
NVS Earnings this Week: How Will it Perform?
21h ago
NVS
Premium
Ratings
Novartis: Buy Rating Backed by Resilient Mid‑Term Outlook and Late‑Stage Pipeline Driving Above‑Consensus Growth Prospects
5d ago
NVS
Premium
Market News
3 Vanguard ETFs That Pay Reliable Dividends
12d ago
RY
COP
Premium
Market News
Novartis to Acquire Myricx Bio for $1.5B to Boost Cancer Drugs; NVS Stock Falls
14d ago
NVS
Premium
The Fly
Novartis agrees to acquire Myricx Bio for up to $1.5B
14d ago
NVS
Premium
The Fly
Novartis to acquire Myricx Bio for $1.1B upfront
14d ago
NVS
Premium
The Fly
Novartis receives EC approval for Itvisma for spinal muscular atrophy
18d ago
NVS
Premium
Ratings
Buy Rating Reaffirmed as Medium-Term Growth Outlook Supports Unchanged $140 Price Target
19d ago
NVS
Premium
The Fly
Anthropic takes aim at pharma industry with Claude Science, STAT reports
20d ago
AZN
BMY
Premium
Ratings
Novartis: Buy Rating Reiterated on Pelacarsen Cardiovascular Upside; $135 Price Target Unchanged
25d ago
NVS
Premium
Market News
SCHD vs. VYMI vs. JEPI: Which Is the Best Dividend ETF for Steady Passive Income?
28d ago
NVS
HSBC
Premium
The Fly
BTIG says others may be interested in Apogee Therapeutics
28d ago
JNJ
NVS
Premium
The Fly
CMS proposes to lock in lower prices in Medicare drug price negotiation program
1M ago
AZN
BMY
Premium
The Fly
Novartis announces Rhapsido met primary endpoints in RemIND trial
1M ago
NVS
Premium
Company Announcements
Novartis Del-brax Trial Hits Key Biomarker Goals in FSHD, Phase III Under Way
1M ago
6K
NVS
Premium
Ratings
Novartis Del-brax Data Bolster FSHD Outlook as Analyst Reiterates Buy and Maintains $135 Price Target
1M ago
NVS
Premium
Ratings
Novartis: Buy Rating Reiterated as Del-brax Data and Late-Stage Pipeline Support Unchanged CHF 140 Price Target
1M ago
NVS
Premium
The Fly
Novartis announces biomarker cohort in study of del-brax met primary endpoint
1M ago
NVS
Premium
The Fly
Novartis, Orionis enter collaboration for molecular glue medicines
1M ago
NVS
Premium
The Fly
Acting FDA head vows to block political interference, Endpoint News says
2M ago
AZN
BMY
Premium
The Fly
Novartis reports final 2.5-year Phase III ALIGN results on Vanrafia
2M ago
NVS
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
